Riot Platforms, Inc. — Director's Dealing 2012

Jul 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-06-29

Reporting Person: PUSEY GREGORY (Director, Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-29	Common Stock	P	2000	$1.94	Acquired	21704	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5136	Direct
Common Stock	2014	Indirect
Common Stock	2465	Indirect
Common Stock	476	Indirect

Footnotes

F1: Reflects a one-for five reverse stock split effected July 29, 2011 and a one-for-six reverse stock split effected June 20, 2012.

F2: Holds jointly with wife.